So I was scratching my head a little bit. The IJO paper was a retrospective cohort study of adults with obesity who had been prescribed a GLP-1 therapy, specifically Saxenda and Ozempic
9 Detailed Analysis of the Violation The "Excel" Problem: The inspection found that "Excel worksheets used to perform chromatogram calculations were not retained" and "several recent Excel spreadsheets used to perform suitability and assay calculations were deleted".9 Excel is a powerful tool, but in a CGMP environment, it is considered "software" that requires validation
Click here to see if you qualify and explore your options
Finally, studies published prior to 2018 were included only if they provided foundational pharmacokinetic or pharmacodynamic data on GLP-1 receptor distribution in the CNS or on the initial development of acylated GLP-1 analogs
Often called the bodys master antioxidant, glutathione plays a central role in neutralizing free radicals, supporting detoxification, and maintaining cellular health